Davis Aaron I.

Insider Reports History

Location
San Diego, CA
Signature
/s/ Davis Aaron I.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Davis Aaron I.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 4.61M $7.23M $1.57 19 Nov 2021 Indirect
Odonate Therapeutics, Inc. Director, 10%+ Owner Common Stock 446K $699K $1.57 19 Nov 2021 Direct
Rain Oncology Inc. Director Common Stock, par value $0.001 per share 0 $0 $1.21 26 Jan 2024 Direct
Tango Therapeutics, Inc. Other* Stock Option (Right to Buy) 65K 03 Sep 2024 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 24.2K 11 Jun 2024 Direct
Mirati Therapeutics, Inc. Director Common Stock 0 $59.02 23 Jan 2024 Direct
Mirati Therapeutics, Inc. Director Option to Purchase Common Stock 0 23 Jan 2024 Direct
Rain Oncology Inc. Director Stock Option (Right to Buy) 0 26 Jan 2024 Direct

Insider Reports Filed by Davis Aaron I.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNGX Tango Therapeutics, Inc. 03 Sep 2024 1 $0 4 05 Sep 2024 Other*
ITOS iTeos Therapeutics, Inc. 11 Jun 2024 1 $0 4 13 Jun 2024 Director
RAIN Rain Oncology Inc. 26 Jan 2024 3 $0 4 26 Jan 2024 Director
MRTX Mirati Therapeutics, Inc. 23 Jan 2024 6 $0 4 23 Jan 2024 Director
MRTX Mirati Therapeutics, Inc. 29 Dec 2023 1 $400K 4 03 Jan 2024 Director
RAIN Rain Oncology Inc. 09 Aug 2023 1 $0 4 11 Aug 2023 Director
ITOS iTeos Therapeutics, Inc. 13 Jun 2023 1 $0 4 15 Jun 2023 Director
TNGX Tango Therapeutics, Inc. 06 Jun 2023 2 $0 4 08 Jun 2023 Director
MRTX Mirati Therapeutics, Inc. 20 Jan 2023 2 $0 4 24 Jan 2023 Director, 10%+ Owner
RAIN Rain Therapeutics Inc. 04 Nov 2022 2 $8M 4 08 Nov 2022 Director
ITOS iTeos Therapeutics, Inc. 09 Jun 2022 1 $0 4 10 Jun 2022 Director
TNGX Tango Therapeutics, Inc. 08 Jun 2022 1 $0 4 28 Jun 2022 Director
RAIN Rain Therapeutics Inc. 01 Jun 2022 1 $0 4 19 Aug 2022 Director
ITOS iTeos Therapeutics, Inc. 09 May 2022 6 -$13.9M 4 11 May 2022 Director
ITOS iTeos Therapeutics, Inc. 28 Apr 2022 5 -$10.2M 4 02 May 2022 Director
ITOS iTeos Therapeutics, Inc. 22 Mar 2022 4 $1.63M 4 24 Mar 2022 Director
MRTX Mirati Therapeutics, Inc. 14 Jan 2022 2 $0 4 18 Jan 2022 Director, 10%+ Owner
ODT Odonate Therapeutics, Inc. 17 Nov 2021 5 -$2.5M 4 19 Nov 2021 Director, 10%+ Owner
ITOS iTeos Therapeutics, Inc. 17 Jun 2021 1 $0 4 21 Jun 2021 Director